Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques
The results provide translational and mechanistic evidence for the potential role of oxytocin as a treatment for psychostimulant use disorders.
Authors
- Ehsan Shokri‐Kojori (ORCID: https://orcid.org/0000-0001-6846-3173)
- Lorenzo Leggio (ORCID: https://orcid.org/0000-0001-7284-8754)
- Mary R. Lee (ORCID: https://orcid.org/0000-0002-2235-0816)
- William J. Dieckmann
- Julie A. Mattison (ORCID: https://orcid.org/0000-0003-4104-8599)
- Erick Singley
- Peter Herscovitch
Institutions
- National Institutes of Health (US)
- National Institute on Drug Abuse (US)
- Johns Hopkins University (US)
- Itron (United States) (US)
- Georgetown University (US)
- Brown University (US)
- Johns Hopkins Medicine (US)
- Veterans Health Administration (US)
- Georgetown University Medical Center (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- National Institute on Aging (US)
- National Institutes of Health Clinical Center (US)
Publication Details
- Journal
- The International Journal of Neuropsychopharmacology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/ijnp/pyae056
- Citations
- 3
- Primary Topic
- Neuroendocrine regulation and behavior
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Aging
- National Institute on Drug Abuse
- NIH Clinical Center
- Office of Behavioral and Social Sciences Research